---
schema_version: "secwatch.filing_event.v1"
accession: "0000910329-25-000015"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:42:49.800689+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medifast Q2 revenue falls 37.4% to $105.6M; active coaches down 33%; Q3 guidance weak

## Summary
- Revenue $105.6M, down 37.4% YoY; active OPTA VIA coaches 22,800 (-32.7% YoY); diluted EPS $0.22 (includes $2.0M net LifeMD gain).
- Net income $2.5M vs. loss $8.2M a year ago; operating loss improved to $1.1M from $7.9M.
- Cash and investments $162.7M, no debt; LifeMD stake sold during quarter.
- Q3 2025 guidance: revenue $70M-$90M; diluted EPS range ($0.60) to $0.00.
- Management cites ongoing client acquisition challenges and GLP-1 competition.

## SEC filing metadata
- accession: 0000910329-25-000015
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000091032925000015/0000910329-25-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000091032925000015/med-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000910329-25-000015
- JSON: https://secwatch.observer/filing/0000910329-25-000015.json
- Plain text: https://secwatch.observer/filing/0000910329-25-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.